JB Capital Partners LP boosted its position in VAREX IMAGING (NASDAQ:VREX - Free Report) by 340.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 110,000 shares of the company's stock after buying an additional 85,000 shares during the period. JB Capital Partners LP owned approximately 0.27% of VAREX IMAGING worth $1,276,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Nuveen Asset Management LLC lifted its holdings in VAREX IMAGING by 0.5% in the fourth quarter. Nuveen Asset Management LLC now owns 161,344 shares of the company's stock valued at $2,354,000 after buying an additional 791 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in VAREX IMAGING by 4.1% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,072 shares of the company's stock valued at $322,000 after buying an additional 864 shares during the period. Barclays PLC lifted its holdings in VAREX IMAGING by 1.1% in the fourth quarter. Barclays PLC now owns 98,964 shares of the company's stock valued at $1,444,000 after buying an additional 1,081 shares during the period. Aquatic Capital Management LLC acquired a new position in VAREX IMAGING in the fourth quarter valued at $25,000. Finally, MetLife Investment Management LLC lifted its holdings in VAREX IMAGING by 8.5% in the fourth quarter. MetLife Investment Management LLC now owns 24,026 shares of the company's stock valued at $351,000 after buying an additional 1,890 shares during the period.
VAREX IMAGING Price Performance
Shares of NASDAQ VREX opened at $11.62 on Friday. The firm's 50-day moving average price is $8.55 and its 200-day moving average price is $9.52. VAREX IMAGING has a 1-year low of $6.76 and a 1-year high of $16.93. The firm has a market capitalization of $482.23 million, a P/E ratio of -3.62 and a beta of 0.68. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78.
VAREX IMAGING (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.14. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. The firm had revenue of $203.00 million for the quarter, compared to analyst estimates of $190.32 million. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. Equities research analysts anticipate that VAREX IMAGING will post 0.53 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on VREX. B. Riley restated a "buy" rating and issued a $16.00 target price (up previously from $12.00) on shares of VAREX IMAGING in a report on Friday, August 8th. Wall Street Zen lowered shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $19.50.
Check Out Our Latest Stock Report on VREX
VAREX IMAGING Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.